RECRUITINGINTERVENTIONAL

A Randomised Clinical Trial of a Digital Self-management Package for People With Interstitial Lung Disease

About This Trial

The goal of this clinical trial is to compare REBUILD-SM (a purpose-built smartphone app and self-management package) with standard care in people with interstitial lung disease (ILD). The main question it aims to answer is: • Does REBUILD-SM improve health-related quality of life, symptoms, anxiety, self-efficacy and physical activity for people with ILD? Participants in the intervention group will work through the self-management package with support from a healthcare professional via phone or Zoom. They will also enter deidentified health data into the RE-BUILD smartphone app to track their progress over time. Participants in the control group will use a reduced functionality version of the smartphone app only. Researchers will compare both groups to see if there is any difference in health-related quality of life, symptoms, anxiety, self-efficacy and level of physical activity.

Who May Be Eligible (Plain English)

Who May Qualify: - Diagnosis of fibrotic ILD - In possession of a smartphone/tablet and an email address - Able to understand written and spoken English - Adequate digital literacy to complete requirements of trial - On stable ILD treatment for 30 days prior to enrolment Who Should NOT Join This Trial: - Not in possession of a smartphone/tablet - Insufficient digital literacy to complete requirements of trial - Unable to communicate in written/spoken English - Not on stable ILD treatment for 30 days prior to enrolment - Acute exacerbation within 30 days prior to enrolment - Participating in pulmonary rehab at enrolment or during 12-week intervention period - Unable to provide willing to sign a consent form Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: * Diagnosis of fibrotic ILD * In possession of a smartphone/tablet and an email address * Able to understand written and spoken English * Adequate digital literacy to complete requirements of trial * On stable ILD treatment for 30 days prior to enrolment Exclusion Criteria: * Not in possession of a smartphone/tablet * Insufficient digital literacy to complete requirements of trial * Unable to communicate in written/spoken English * Not on stable ILD treatment for 30 days prior to enrolment * Acute exacerbation within 30 days prior to enrolment * Participating in pulmonary rehab at enrolment or during 12-week intervention period * Unable to provide informed consent

Treatments Being Tested

BEHAVIORAL

Pulmonary Fibrosis self-management package and smartphone application

The pulmonary fibrosis package includes modules on understanding treatment options for pulmonary fibrosis, managing medication and side effects, understanding and accessing clinical trials, managing shortness of breath, managing fatigue and mood, managing co-existing conditions, the role and importance of pulmonary rehabilitation and regular physical activity, role of oxygen therapy, smoking cessation advice and support, accessing community support, and communicating with others when living with pulmonary fibrosis. The RE-BUILD app is used as a tool for data collection and to help participants self-monitor their disease over time. Participants enter their health data, including baseline conditions, medications and diagnosis, pulmonary function results and supplementary oxygen use. It also tracks air quality data close to the participant as well as physical activity level (step count). The app also has links to ILD-related educational resources.

Locations (4)

Royal Prince Alfred Hospital

Sydney, New South Wales, Australia

The Prince Charles Hospital

Brisbane, Queensland, Australia

Alfred Hospital

Melbourne, Victoria, Australia

Austin Health

Melbourne, Victoria, Australia